We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cbaysystems | CBAY | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 139.50 | 01:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 139.50 |
| Top Posts |
|---|
Posted at 07/9/2009 16:50 by stegrego Well it wasnt me who sold..... come on own up!Notice that 'Jefferies' have supposedly downgraded Cbay today to a hold. CBaySystems Holdings (Reg S) CBAY Jefferies Hold 68.00p 62.00p 76.00p DownGrade Although the target price is now given as 76 rather than 62p from what i can gather (which isnt much!) 'downgrades CBay Systems to hold from buy with a 76p target.' |
Posted at 02/9/2009 23:45 by stegrego MedQuist, Inc. Announces Establishment Of Revolving Credit Facility And Payment Of Special Cash Dividend5:00pm EDT MedQuist, Inc. announced it has entered into a five-year $25 million revolving credit facility. The credit facility provides committed revolving funding through August 2014 and includes an option whereby the Company may increase its maximum credit up to $40 million, based on certain terms and conditions. The credit facility is a working capital facility that may be used for general corporate purposes. The Company does not currently anticipate borrowing under the credit facility. The Company also announced that the Board of Directors, at a meeting held on August 27, 2009, unanimously declared a special cash dividend of $1.33 per share on MedQuist's common stock. The dividend will be paid on September 15, 2009, to shareholders of record as of the close of business on September 9, 2009. -------------------- MedQuist Announces Establishment of Revolving Credit Facility and Payment of Special Cash Dividend MOUNT LAUREL, N.J., Sept. 2 /PRNewswire-FirstCal Separately, the MedQuist Board of Directors, at a meeting held on August 27, 2009, unanimously declared a special cash dividend of $1.33 per share on MedQuist's common stock. The dividend will be paid on September 15, 2009 to shareholders of record as of the close of business on September 9, 2009. While the analysis of the tax impact of the dividend has not been completed, the Company expects a significant portion of the distribution will not be a taxable dividend for U.S. income tax purposes. Robert Aquilina, Chairman of the Board, stated, "In declaring this special cash dividend, the Board considered the Company's financial position, earnings, earnings outlook, capital spending plans and other relevant factors. The Board continues to explore opportunities to enhance returns on shareholder equity." -------------------- So thats a big divi payment to CBAY then? Or us? |
Posted at 25/8/2009 08:41 by 237gmoney I thought Phillips paid $2bn for Medquist? I think the news yesterday was good for Cbay as that director never liked Cbay buying MEDQ for what they paid. CBay have one less cog to worry about in the boardroom. I think the rise in MEDQ over the last few days is also helping the price upwards here. |
Posted at 24/8/2009 16:39 by 237gmoney I found this article out in the states on another victory for CBAY today. this should move things along quicker....Now CBay can do what they like....Also I only realised CBAY only paid $7.50 a share upfront for MEDQ in 2008 with the remaining $3.50 to be paid with a 7 yr bond. so that will not mature until 2015 which means MEDQ could be quids in by that time. Therefore the invest in MEDQ was only for 130m Euros upfront and not the $287m reported at the time of the deal althought thats what the deal will eventually cost. |
Posted at 20/8/2009 18:18 by nurdin I see MedQ is straddling $9 now and is on a breakout...not that it will make diddly bit of difference to the CBays share price..For what its worth ,CBay stake in MedQ currently worth £143m....CBays market cap £78m |
Posted at 08/8/2009 15:45 by stegrego Comment on CBAY in this months SCSW i see, first comment on it in over a year might get some attention come Monday - cant read it except for this bit...'CBAY has reported its Q1 09 results, which mark the beginning of quarterly reporting. This is on the back of the transformational deal in 2008 when the young new kid on the block, CBAY, bought its majority (69.5%) stake in Medquist, a much more substantial and longstanding business in the US.' |
Posted at 05/8/2009 09:17 by nurdin Nice to see some interest here...and yes the US GAAP reporting standard does confuse the issues.But once you sift through the numbers,its not hard to work out the underlying operating performance imo. -MedQ have already reported non-GAAP (ie adjusted) EBITDA of $28.5m for the six months to June -tax rate sems to be about 12%...low but presumably due to past losses? -net adjusted earnings on that basis is therefore $25m...or £15,2m at the current exchange rate ($1.65 to £) -CBays share of the earnings works out to be around £10.64m...or around £21m annualised -full year eps for CBay should be atleast 13.5p..just on MedQ contribution -CBay therefore appear to be trading on a PE of around 3.3 if my sums are correct....could be much lower if we add CBay contribution which is as yet unknown -cheap I think |
Posted at 29/6/2009 22:55 by stegrego I assume this is why the share has jumped....MedQuist Inc. (the "Company") entered into a Settlement and License Agreement (the "Settlement Agreement") by and between Anthurium Solutions, Inc. ("Anthurium") and the Company on June 19, 2009 (the "Effective Date"). As previously disclosed by the Company, on November 6, 2007, Anthurium filed an action (the "Lawsuit") entitled Anthurium Solutions, Inc. v. MedQuist Inc., et al., Civil Action No. 2-07CV-484, in the United States District Court for the Eastern District of Texas, seeking damages for the alleged infringement by the Company of United States Patent No. 7,031,998 (the "'998 Patent") through the Company's DocQment™ Enterprise Platform ("DEP"). The Company denies the allegations set forth in the complaint filed by Anthurium in the Lawsuit and asserted affirmative defenses alleging that the '998 patent is invalid, not infringed and unenforceable. Pursuant to the Settlement Agreement, Anthurium will receive $5,750,000 from the Company and $100,000 from CBay Systems Holdings, Ltd. ("CBay Holdings") in return for a non-exclusive, fully paid-up, royalty-free, and worldwide license of the Anthurium Patents to the Company, the Company's subsidiaries, CBay Holdings and the medical transcription companies controlled by CBay Holdings (collectively referred to as the "MedQuist Affiliates"). The settlement for the Company and its subsidiaries was negotiated separately and independently from the settlement for CBay Holdings and the other medical transcription companies controlled by CBay Holdings. For convenience, both settlements were addressed in the single Settlement Agreement. The Anthurium Patents are defined as (i) the '998 Patent, (ii) any other patent owned or controlled by Anthurium as of the Effective Date, (iii) any patent which issues after the Effective Date from an application owned or controlled by Anthurium prior to the Effective Date and (iv) any and all other patents and applications from which any or all of the foregoing patents claim priority or are derived through continued prosecution, division, continuation, continuation-in-part The Settlement Agreement further provides that the MedQuist Affiliates and Anthurium release one another from any and all liability or obligations, past or present, arising under, out of, or in any manner connected with the alleged infringement of the Anthurium Patents. In addition, pursuant to the Settlement Agreement, Anthurium is precluded from asserting against the MedQuist Affiliates any claim arising from or related to any infringement, misappropriation or violation of any intellectual property right (other than a trademark right), for a period of three (3) years following the Effective Date. The Company has not admitted nor will it admit to liability or any wrongdoing in connection with the settlement. The Company has no material relationship with Anthurium other than the Lawsuit and the Settlement Agreement. CBay Holdings is the parent of the Company's majority shareholder, CBay, Inc., which owns approximately 70% of the Company's outstanding common stock. The Company will file a copy of the Settlement Agreement as an exhibit to its Quarterly Report on Form 10-Q for the quarter ended June 30, 2009. |
Posted at 22/5/2009 08:08 by nurdin Hi StegA litttle bit of background first. -Cbay acquired MedQ from Philips at a price of $287m back in May08 -I understand Philips themselves had paid $2bn for MedQ,seemingly to get ownership of their sophiisticatd speech recognition technology -Cbays acquisition was paid for as follows: $98m in cash $91m in convertible loans $98m bridging loan -to fund the acquisition, Cbay placed $123m with Sac Private and Lehman Brothers -at the the time of the acquisition MedQ had copious cash on the balance sheet ($120m from memory but will check on that) -the collapse in MedQs share price post Cbays acquisition was triggered by ,first the the severe down turn in the broader markets, second the adverse publicity stemming from the 16 class actions that MedQ faced and thirdly,the poor market perception of MedQs management -I also suspect that Lehman became forced sellers during the hiatus of last year Current -all class actions have now been resolved and settled -new management team has been installed who appear to be turning the business around nicely -the management did a kitchen sink job on their FY08 results, reporting severe impairement losses and charges from the legal actions -nevertheless they reported pre exceptional EBITDA of $27m for the year -Q1 09 results underpins the turn around there but there are likely to be further impairement charges this year..need to look into that though. -I have no idea what the Cbay results on Tuesday will show but a recent conversation with the company suggested trading is strong.... not sure what their cashflow is like though You are right though that there is very thin trading in Cbay..perhaps because the stock is not known that well? The lack of liquidity in the shares doesnt help either. It has to be your call my friend but I feel Cbay are grossly mis priced here |
Posted at 13/5/2009 11:15 by nurdin Dont know if anyone is following CBAY but they look fundamentally mispriced at current levels imo.Here is why:-they own 69.5% of the Nasqaq listed Medquist -Medquist have been transformed by the new management installed there by Cbay -all the outstanding legal actions faced by Medquist have now been resolved and settled in and out of court. -the management did a 'kitchen sink' job on last years results which didnt look pretty -the transformation has been appreciated by the US investors and the Medquist share price has risen sharply on Nasdaq specially after they reported their 09 Q1 results: -medquist are currently capitalised at $165m(£110m) against Cbays market cap of just £51m -MedQ reported earnings of $6.8m for Q1.Annualised, that translates to $27.2m,ignoring any benefits of synergies between Cbay and MedQ which are on going. -so Cbay look to report earnings of $19m or £12.7m from the Medq ownership alone -with 155m shares in issue,that translates into eps of about 8p, just from MedQ operations alone -Cbay themselves are doing very well(so I understand) and could easily add another 4p minimum to earnings -that values Cbay on an earnings multiple of 2.9 !! Way too cheap if you ask me,specially given that they stand to benefit significantly from Obamas Healthecare reforms announced recently |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
